Earnings History Data for Foghorn Therapeutics (FHTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Foghorn Therapeutics
Foghorn Therapeutics Inc. engages in the discovery and development of medicines targeting genetically determined dependencies within the chromatin regulatory system. Foghorn Therapeutics Inc. is based in CAMBRIDGE, Mass.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 04-11-2024 | AH | FHTX | Foghorn Therapeutics | 422.00 | -0.31 | -0.42 | 0.00 | Foghorn Therapeutics GAAP EPS of -$0.31 beats by $0.13, revenue of $7.81M beats by $0.8M [11/4/2024 5:42 PM] |
8.93 | 0.69 (8.37%) |
8.24 | 0.0 (0.00%) |
2.70 - 10.25 | 110,415 | 110,000 | 1,720 | ||
|
||||||||||||||||||
| 08-08-2024 | PM | FHTX | Foghorn Therapeutics | 235.00 | -0.45 | -0.60 | 0.00 | Foghorn Therapeutics GAAP EPS of -$0.45, revenue of $6.88M [8/8/2024 8:15 AM] |
5.19 | 0.15 (2.98%) |
5.10 | 0.06 (1.19%) |
2.70 - 9.97 | 79,435 | 80,000 | 2,031 | ||
| 06-05-2024 | PM | FHTX | Foghorn Therapeutics | 260.00 | -0.59 | -0.55 | 0.00 | Foghorn Therapeutics GAAP EPS of -$0.59, revenue of $5.1M [5/6/2024 7:58 AM] |
5.91 | -0.08 (-1.34%) |
0.0 | 0.0 (0.00%) |
2.70 - 9.97 | 24,214 | 50,000 | 0 | ||
| 07-03-2024 | PM | FHTX | Foghorn Therapeutics | 270.00 | -0.57 | -0.79 | 0.00 | 6.85 | 0.06 (0.88%) |
7.29 | 0.50 (7.36%) |
2.70 - 9.97 | 109,216 | 140,000 | 748 | |||
|
|
||||||||||||||||||
| 02-11-2023 | PM | FHTX | Foghorn Therapeutics | 140.00 | -0.34 | -0.72 | 0.00 | Foghorn Therapeutics GAAP EPS of $0.34 beats by $1.09, revenue of $17.48M beats by $11.83M [11/2/2023 11:19 AM] |
3.94 | 0.26 (7.07%) |
3.94 | 0.0 (0.00%) |
2.84 - 9.97 | 322,313 | 80,000 | 1,078 | ||
| 04-08-2023 | PM | FHTX | Foghorn Therapeutics | 384.00 | -0.70 | -0.73 | 0.00 | 9.25 | -0.01 (-0.11%) |
0.0 | 0.0 (0.00%) |
4.51 - 18.12 | 58,057 | 60,000 | 0 | |||
|
|
||||||||||||||||||